<DOC>
	<DOC>NCT00908115</DOC>
	<brief_summary>The purpose of this study was to investigate the following questions through post-marketing surveillance: - Unknown/Unexpected adverse events and the serious adverse events. - The circumstances in which the adverse events occurred under the practical application. - Factors considered to have influence on safety. - Factors considered to have influence on efficacy. - Miscellaneous - Facts about mechanism, efficacy and safety which were not clearly known due to the inherent problems of the drugs.</brief_summary>
	<brief_title>Post Market Surveillance for Infanrix™</brief_title>
	<detailed_description />
	<mesh_term>Diphtheria</mesh_term>
	<criteria>All children receiving Infanrix™ were eligible for this survey.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>